Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.99B |
| 2 |
Eli Lilly
LLY
|
+$3.22B |
| 3 |
UnitedHealth
UNH
|
+$2.21B |
| 4 |
Amazon
AMZN
|
+$2.17B |
| 5 |
Applied Materials
AMAT
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$6.48B |
| 2 |
Boeing
BA
|
+$4.34B |
| 3 |
Royal Caribbean
RCL
|
+$2.21B |
| 4 |
Broadcom
AVGO
|
+$1.17B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Consumer Discretionary | 12.86% |
| 3 | Healthcare | 12.73% |
| 4 | Industrials | 10.59% |
| 5 | Financials | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Comfort Systems
FIX
$60.8B
| $126M | 0.02% |
152,607
-23,053
| -13% | -$15.6M |
|
277
Lamb Weston
LW
$7.39B
| $125M | 0.02% |
2,150,000
+680,000
| +46% | +$37.2M |
|
278
Sterling Infrastructure
STRL
$16.9B
| $124M | 0.02% |
364,830
+186,122
| +104% | +$52.8M |
|
279
Q2 Holdings
QTWO
$4.13B
| $122M | 0.02% |
1,686,968
| – | – |
|
|
LINE
280
Lineage Inc
LINE
$9.8B
| $122M | 0.02% |
3,152,949
+120,616
| +4% | +$5.01M |
|
281
Microchip Technology
MCHP
$42.2B
| $121M | 0.02% |
1,887,854
-13,762,481
| -88% | -$933M |
|
282
SiriusPoint
SPNT
$2.7B
| $121M | 0.02% |
6,700,000
+1,000,000
| +18% | +$18.7M |
|
283
Lazard
LAZ
$4.43B
| $118M | 0.02% |
2,235,512
-130,799
| -6% | -$7.05M |
|
284
Bio-Rad Laboratories Class A
BIO
$9.66B
| $117M | 0.02% |
+418,355
| New | +$114M |
|
285
Danaher
DHR
$143B
| $114M | 0.02% |
573,394
+2,845
| +0.5% | +$566K |
|
286
ConocoPhillips
COP
$150B
| $108M | 0.02% |
1,143,187
+4,991
| +0.4% | +$472K |
|
287
Silicon Laboratories
SLAB
$7.28B
| $106M | 0.02% |
811,937
-395,000
| -33% | -$53.8M |
|
288
Pinnacle Financial Partners Inc
PNFP
$16.2B
| $106M | 0.02% |
1,131,294
| – | – |
|
289
Acushnet Holdings
GOLF
$5.25B
| $106M | 0.02% |
1,350,000
| – | – |
|
|
AL
290
DELISTED
Air Lease Corp
AL
| $103M | 0.02% |
1,625,000
-425,000
| -21% | -$25.4M |
|
291
Black Hills Corp
BKH
$5.64B
| $101M | 0.02% |
1,641,122
| – | – |
|
292
BridgeBio Pharma
BBIO
$15.9B
| $100M | 0.02% |
1,933,126
-2,055,172
| -52% | -$100M |
|
293
Brookfield
BN
$111B
| $99.7M | 0.02% |
+2,179,109
| New | +$96.6M |
|
294
Rogers Corp
ROG
$2.46B
| $98.3M | 0.02% |
+1,221,660
| New | +$91M |
|
295
Genius Sports
GENI
$2.2B
| $97.4M | 0.02% |
7,869,105
-6,079,556
| -44% | -$72.7M |
|
296
New York Times
NYT
$10.3B
| $97.2M | 0.02% |
1,692,846
+4,782
| +0.3% | +$273K |
|
297
Grand Canyon Education
LOPE
$3.79B
| $95.7M | 0.02% |
436,021
-16,827
| -4% | -$3.23M |
|
298
Patrick Industries
PATK
$2.78B
| $94.6M | 0.02% |
914,516
| – | – |
|
299
Emerson Electric
EMR
$91.6B
| $91.8M | 0.02% |
700,037
+6,400
| +0.9% | +$873K |
|
300
KT
KT
$9.03B
| $91.2M | 0.02% |
4,674,380
+47,083
| +1% | +$960K |
|
Similar funds
Capital Research Global Investors's Q3 2025 Portfolio in Review
As of Q3 2025, Capital Research Global Investors held 458 positions worth $533B, up 6.7% from $499B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Capital Research Global Investors's Q3 2025 filing shows 30 new, 198 increased, 163 reduced and 25 closed positions. Its largest new stake was Corning: 11,058,929 shares worth $907M. The largest sale was Meta Platforms (Facebook), an estimated $6.48B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Capital Research Global Investors's largest Q3 2025 buy was Corning: 11,058,929 shares worth $907M.
- Capital Research Global Investors added most to NVIDIA in Q3 2025, an estimated $3.99B increase.
- Capital Research Global Investors's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $6.48B.
- Capital Research Global Investors fully exited Ansys in Q3 2025, selling an estimated $984M.
- Capital Research Global Investors's ten largest holdings make up 38% of its $533B portfolio in Q3 2025.
- Capital Research Global Investors opened 30 new positions and closed 25 in Q3 2025.
- Capital Research Global Investors's portfolio value rose 6.7% quarter-over-quarter to $533B.
Based on Capital Research Global Investors's 13F filing for Q3 2025, filed 13 Nov 2025.